ENZYVANT SCIENCES

enzyvant-sciences-logo

Enzyvant Sciences is a biotechnology company which focuses on developing treatments for rare diseases.

#SimilarOrganizations #People #Website #More

ENZYVANT SCIENCES

Social Links:

Industry:
Biopharma Biotechnology Health Care Medical

Address:
Basel, Basel-Stadt, Switzerland

Country:
Switzerland

Website Url:
http://www.enzyvant.com

Total Employee:
11+

Status:
Active

Contact:
+41612254202

Email Addresses:
[email protected]

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Google Tag Manager WordPress Content Delivery Network


Similar Organizations

apatech-logo

ApaTech

ApaTech is an orthobiologics company producing synthetic bone repair materials.

autolomous-logo

Autolomous

Autolomous is an biotechnology company engaged in manufacturing pragmatic digital solutions for cell and gene therapy.

biomeb-logo

Biomeb

Biomeb is a biotechnology company that provide personalized medicine for prevention, diagnosis and treatment of different pathologies.

cellnlife-logo

CELLnLIFE

CELLnLIFE develops stem cell therapy for the treatment of rare and intractable diseases.

certis-usa-logo

Certis USA

Certis USA is a biotechnology company specializing in biological product development solutions.

ers-genomics-logo

ERS Genomics

ERS Genomics is a biotechnology company to provide broad access to the foundational CRISPR-Cas9 intellectual property.

genea-logo

Genea

Genea provides assisted reproductive technology products and services alongside its subsidiaries.

glycomar-logo

GlycoMar

GlycoMar is a biotechnology company developing products for the human healthcare and personal care markets.

gpc-biotech-logo

GPC Biotech

GPC Biotech is a German biopharmaceutical company that discovers and develops anticancer drugs.

henry-ford-health-system-logo

Henry Ford Health System

Henry Ford Health System (HFHS) is one of the nation’s leading comprehensive, integrated health systems.

igen-biotech-logo

Igen Biotech

Igen Biotech is a biotechnological company that translates biomedical research into practical and marketable medical devices and services.

not_available_image

Inatherys

Inatherys is a biotechnology company developping monoclonal antibodies for the treatment of cancers and inflammatory diseases.

lifearc-logo

LifeArc

LifeArc is an independent life science medical research charity committed to drastically improving positive patient outcomes everywhere.

neodynamics-logo

NeoDynamics

This company is a Swedish medical technology company focused on improving the diagnosis and treatment of breast cancer.

neurotec-pharma-logo

Neurotec Pharma

Neurotec Pharma is focused on developing new treatments for acute and chronic central nervous system (CNS) diseases.

orox-biosciences-logo

OROX BioSciences

OROX BioSciences is a biotechnology start-up focused on the rapid discovery and development of novel small molecule medications.

oxolife-logo

OXOlife

Oxolife is a biotechnology company in the clinical phase of development.

oxxon-therapeutics-logo

Oxxon Therapeutics

Oxxon Pharmaccines Ltd., an Oxford, UK-based biotech company focused on immunotherapies.

pharmaceutical-biotechnology-logo

Pharmaceutical Biotechnology

Pharmaceutical Biotechnology focuses on the development and implementation of new biotech projects with high market potential.

procella-therapeutics-logo

Procella Therapeutics

Procella Therapeutics is an early stage biotechnology company focused on developing cardiac stem cell technology.

prolocor-logo

Prolocor

Prolocor is a biotechnology company that develops diagnostic tests for cardiovascular diseases.

protomer-technologies-logo

Protomer Technologies

Protomer Technologies is a biotechnology company that focuses on metabolic diseases.

rd-systems-logo

R&D Systems

R&D Systems is a product and services agency bringing together resources for Cell Biology research.

radiopharma-logo

Radiopharma

Radiopharma engages in nuclear medicine and molecular imaging for the diagnosis and treatment of several diseases.

retina-implant-logo

Retina Implant

Retina Implant is a biotech company which develops subretinal implants for partially sighted and blind patients.

stemmatters-logo

Stemmatters

Stemmatters is a biotechnology company focused on regenerative medicine.

wellcome-trust-logo

Wellcome Trust

Wellcome Trust is a medical research charity that funds research that aims to protect and improving human and animal health.

xenova-logo

Xenova

Xenova publicly quoted biotechnology company focused on the development of novel drugs to treat cancer and addiction.

Current Employees Featured

judy-chuk_image

Judy Chuk
Judy Chuk VP of Strategy and Operations @ Enzyvant Sciences
VP of Strategy and Operations
2017-02-01

johanna-rossell_image

Johanna Rossell
Johanna Rossell Chief Commercial Officer @ Enzyvant Sciences
Chief Commercial Officer
2022-01-01

bill-symonds_image

Bill Symonds
Bill Symonds CEO @ Enzyvant Sciences
CEO
2022-03-01

Official Site Inspections

http://www.enzyvant.com Semrush global rank: 5.51 M Semrush visits lastest month: 1.55 K

  • Host name: 141.193.213.20
  • IP address: 141.193.213.20
  • Location: United States
  • Latitude: 37.751
  • Longitude: -97.822
  • Timezone: America/Chicago

Loading ...

More informations about "Enzyvant Sciences"

Enzyvant Announces Merger with Altavant - Yahoo Finance

Dec 6, 2022 Combined company has full range of capabilities required to advance bold science for rare diseases in immunology and cardiopulmonologyCARY, N.C., Dec. 06, 2022 (GLOBE …See details»

Enzyvant Announces Merger with Altavant - GlobeNewswire

Dec 6, 2022 A nimble and unique organization, Enzyvant has a full range of capabilities spanning non-clinical and clinical development and commercialization and is developing in …See details»

Enzyvant Sciences - Crunchbase Company Profile

Organization. Enzyvant Sciences . Connect to CRM . Save . Summary. People. Technology. Signals & News. Similar Companies. ... Enzyvant Sciences is a biotechnology company which focuses on developing treatments for rare …See details»

Sumitomo Pharma Subsidiary Companies in the U.S., Including …

Apr 3, 2023 A nimble and unique organization, Enzyvant has a full range of capabilities spanning non-clinical and clinical development and commercialization and is developing in house …See details»

Inside The Altavant/Enzyvant Self-Made Merger

Dec 21, 2022 Enzyvant’s allogeneic processed thymus tissue–agdc, RETHYMIC, was approved for the treatment of congenital athymia in pediatric patients in 2021. ... its lead candidate,” says Symonds. Where there was no …See details»

Enzyvant Stages NC HQ for Rare-Disease Battles

Enzyvant Therapeutics, Inc. and Altavant Sciences, Inc., both wholly owned subsidiaries of the global biopharmaceutical giant Sumitovant Biopharma Ltd., today announced a merger to form …See details»

Enzyvant Merges with Altavant to Advance Therapies for Rare …

Dec 7, 2022 Enzyvant is developing an in-house regenerative medicine manufacturing facility in North Carolina that is expected to be completed in the second half of 2024. The facility will …See details»

More biotech jobs, company HQ coming to Triangle in life science …

Dec 6, 2022 Enzyvant Therapeutics, Inc. and Altavant Sciences, Inc., both wholly owned subsidiaries of the global biopharmaceutical giant Sumitovant Biopharma Ltd., today …See details»

Enzyvant Announces Merger with Altavant | American …

Dec 6, 2022 The combined company retains the name Enzyvant and is equipped with a full range of capabilities spanning non-clinical and clinical development and commercialization …See details»

Enzyvant and Altavant announce merger to accelerate rare

Dec 8, 2022 The combined company, which retains the name Enzyvant, will have a full range of capabilities required to advance ‘bold science’ for rare diseases in immunology and …See details»

Enzyvant Announces Merger With Altavant - Drug Development …

A nimble and unique organization, Enzyvant has a full range of capabilities spanning non-clinical and clinical development and commercialization and is developing in-house manufacturing. …See details»

Enzyvant Company Profile - Office Locations, Competitors ... - Craft

Enzyvant is a company developing transformative therapies for people with rare diseases. Its pipeline includes investigational regenerative medicine therapies for T cell–implicated …See details»

Enzyvant Announces Merger with Altavant - DistilINFO LifeSciences

Dec 12, 2022 A nimble and unique organization, Enzyvant has a full range of capabilities spanning non-clinical and clinical development and commercialization and is developing in …See details»

Enzyvant Receives 2022 Rare Impact Industry Innovation

Jun 27, 2022 Enzyvant Receives 2022 Rare Impact Industry Innovation Award from the National Organization for Rare Disorders (NORD) for Novel, Tissue-Based Therapy to Treat Ultra-Rare, …See details»

Enzyvant Announces Merger with Altavant - BioSpace

Dec 6, 2022 A nimble and unique organization, Enzyvant has a full range of capabilities spanning non-clinical and clinical development and commercialization and is developing in …See details»

Enzyvant Announces Plans to Expand Regenerative Medicine …

Apr 21, 2022 Enzyvant. State-of-the-art facility will expand capacity for producing tissue-based and additional regenerative medicines. CAMBRIDGE, Mass. and BASEL, Switzerland, April …See details»

Enzyvant Receives 2022 Rare Impact Industry Innovation Award …

Jun 27, 2022 Company honored for its work on RETHYMIC® (allogeneic processed thymus tissue-agdc), a one-time, treatment for congenital athymia, an ultra-rare, severe …See details»

Enzyvant Announces Plans to Expand Regenerative Medicine …

“Enzyvant is committed to ensuring scalable GMP manufacturing for RETHYMIC ® (allogeneic processed thymus tissue-agdc), and we’re looking ahead to potential needs in other …See details»

Enzyvant Receives FDA Approval for RETHYMIC® (allogeneic

Sep 10, 2021 Enzyvant’s RETHYMIC ® (previously RVT-802) is a one-time tissue-based regenerative therapy approved by the U.S. Food and Drug Administration for pediatric …See details»

Enzyvant Announces Plans to Expand Regenerative Medicine

Apr 21, 2022 Enzyvant is a commercial-stage biotechnology company with a focus on regenerative medicines for rare diseases. The company’s first commercial product is U.S. …See details»

linkstock.net © 2022. All rights reserved